Question 1

What is the catalog number for Tissue FFPE Sections, Breast?

Accepted Answer

The catalog number for Tissue FFPE Sections, Breast is CS701602.

Question 2

What sizes are available for Tissue FFPE Sections, Breast?

Accepted Answer

Tissue FFPE Sections, Breast is available in the following size(s): 5x 5 µm.

Question 3

Is Tissue FFPE Sections, Breast in stock?

Accepted Answer

Tissue FFPE Sections, Breast is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Tissue FFPE Sections, Breast?

Accepted Answer

The safety data sheet for Tissue FFPE Sections, Breast is available here: https://cdn.origene.com/sds/cs701602.pdf.

Question 5

What is Tissue FFPE Sections, Breast used for?

Accepted Answer

Tissue Sections (5x5um), FFPE; Breast; Fibrocystic breast disease

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 7

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 8

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Tissue FFPE Sections, Breast

Product Specifications

Stability

Storage Conditions

Frequently Asked Questions

Explore Other Products

SNCG 3'UTR GFP Stable Cell Line

Human RWDD2B Pre-designed siRNA Set B

CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (APC)

CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (APC)

CITED4 (Cbp/p300-interacting Transactivator 4, MSG1-related Protein 2, MRG-2, MRG2) (MaxLight 750) discontinued

GH1 Antibody